OncoSec Medical, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Services » Medical Or Nursing Services
DVADaVita, Inc. 1.88%80.963.2%$92.87m
SDCSmileDirectClub, Inc. 2.36%7.810.0%$91.70m
GHGuardant Health, Inc. 2.89%90.390.0%$80.44m
LHCGLHC Group, Inc. 1.61%162.512.9%$63.14m
AMEDAmedisys, Inc. 0.59%192.0511.5%$56.61m
CHEChemed Corp. -0.76%478.6010.1%$54.76m
NTRANatera, Inc. 0.94%43.851.3%$41.63m
ONEM1Life Healthcare, Inc. 3.86%32.300.0%$39.99m
NVTAInvitae Corp. -1.75%16.842.0%$36.86m
NEONeoGenomics, Inc. -3.51%26.695.7%$36.11m
ACHCAcadia Healthcare Co., Inc. -2.55%28.6127.1%$24.59m
MDMEDNAX, Inc. -2.69%15.5311.1%$21.10m
ENSGThe Ensign Group, Inc. -2.50%43.725.7%$18.73m
TVTYTivity Health, Inc. -0.28%10.659.0%$15.78m
ADUSAddus HomeCare Corp. 2.16%98.961.0%$13.57m

Company Profile

OncoSec Medical, Inc. is a biotechnology company, which engages in designing, developing, and commercializing therapies for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.